未名醫藥(002581.SZ):未名集團所持股份被輪候凍結
格隆匯12月3日丨未名醫藥(002581.SZ)公佈,公司在中國證券登記結算有限責任公司深圳分公司查詢證實,公司控股股東北京北大未名生物工程集團有限公司(“未名集團”)所持有的公司股份被法院輪候凍結,其中,1.輪候凍結1.76億股,委託日期2019年11月26日,輪候期限36個月,輪候凍結執行人北京市第一中級人民法院,佔其所持股份比例100%;2.輪候凍結1.76億股,委託日期2019年12月2日,輪候期限36個月,輪候凍結執行人福建省廈門市中級人民法院,佔其所持股份比例100%。
截至公告披露日,未名集團持有公司股份1.76億股,佔公司股份總數的26.73%,其所持有公司股份累計被法院凍結及輪候凍結1.76億股,佔其所持公司股份的100%,佔公司總股本的26.73%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.